Robert Malcolm to Treatment Outcome
This is a "connection" page, showing publications Robert Malcolm has written about Treatment Outcome.
Connection Strength
0.431
-
A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
Score: 0.046
-
Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
Score: 0.036
-
Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
Score: 0.035
-
The impact of loss to follow-up on hypothesis tests of the treatment effect for several statistical methods in substance abuse clinical trials. J Subst Abuse Treat. 2009 Jul; 37(1):54-63.
Score: 0.034
-
An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
Score: 0.030
-
Modafinil and cocaine interactions. Am J Drug Alcohol Abuse. 2006; 32(4):577-87.
Score: 0.028
-
A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
Score: 0.026
-
A Double-Blind Randomized Controlled Trial of Doxazosin for Co-Occurring PTSD and Alcohol Use Disorder in Veterans. J Clin Psychiatry. 2023 Mar 08; 84(2).
Score: 0.023
-
New anticonvulsants: a review of applications for the management of substance abuse disorders. Ann Clin Psychiatry. 2002 Dec; 14(4):233-45.
Score: 0.022
-
Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
Score: 0.020
-
Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
Score: 0.018
-
Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
Score: 0.016
-
Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995 Jul; 39(1):69-71.
Score: 0.013
-
Emotional eating, marital status and history of physical abuse predict 2-year weight loss in weight loss surgery patients. Eat Behav. 2014 Dec; 15(4):619-24.
Score: 0.013
-
Potential role of N-acetylcysteine in the management of substance use disorders. CNS Drugs. 2014 Feb; 28(2):95-106.
Score: 0.012
-
Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
Score: 0.012
-
Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
Score: 0.012
-
A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
Score: 0.009
-
Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse. 2007 Mar; 61(3):150-6.
Score: 0.008
-
Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64.
Score: 0.005
-
Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998 Nov; 155(11):1632.
Score: 0.004
-
Naltrexone treatment of self-injurious thoughts and behaviors. J Nerv Ment Dis. 1996 Mar; 184(3):192-5.
Score: 0.004
-
Alcohol treatment: measurement of effectiveness by global outcome. Soc Work Health Care. 1996; 23(3):57-71.
Score: 0.003
-
Treatment of panic disorder and comorbid substance abuse with divalproex sodium. Am J Psychiatry. 1994 Oct; 151(10):1521.
Score: 0.003